Although nuclear factor erythroid-related factor 2 (Nrf2) was suggested as a target of SFA to explain its antidiabetic effects [22], recent evidence suggested that SFA might have additional actions relevant to metabolic diseases [23,24]. Here, NFE2L2 is linked to Other metabolic disease.